Recon: Pfizer mulls over selling hospital drugs business; AstraZeneca plans $2B for US production, R&D boost

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States